Nuvation Bio Inc.
NYSE: NUVB-WT0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- New York Stock Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- David Hung
- Employees
- 72
- Headquarters
- New York, United States
- IPO year
- 2021
- Market cap
- $19.5M
- Website
- https://www.nuvationbio.com
Loading NUVB-WT…
Loading profile data…Frequently asked questions about NUVB-WT
What does Nuvation Bio Inc. (NUVB-WT) do?
Nuvation Bio Inc. is a clinical-stage biopharmaceutical company focused on developing targeted therapies for oncology. The company's pipeline includes small molecule drug candidates aimed at treating various types of cancer. Its strategy involves acquiring and developing novel therapeutic candidates to address significant unmet medical needs in...
Where does NUVB-WT trade?
Nuvation Bio Inc. (NUVB-WT) trades on the New York Stock Exchange.
What sector is NUVB-WT in?
Nuvation Bio Inc. (NUVB-WT) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Nuvation Bio Inc.?
David Hung is the chief executive officer of Nuvation Bio Inc. (NUVB-WT).
Where is Nuvation Bio Inc. headquartered?
Nuvation Bio Inc. is headquartered in United States.
Does NUVB-WT pay a dividend?
Nuvation Bio Inc. (NUVB-WT) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did NUVB-WT go public?
Nuvation Bio Inc. (NUVB-WT) completed its initial public offering in 2021.